Texas Attorney General Ken Paxton accused Pfizer and its supplier Tris Pharma of providing children's ADHD medicine that it knew might be ineffective to the state's Medicaid insurance program for low-income people, in a lawsuit unsealed on Monday.
Nov 20 (Reuters) - Texas Attorney General Ken Paxton accused Pfizer (PFE.N) and its supplier Tris Pharma of providing children’s ADHD medicine that it knew might be ineffective to the state’s Medicaid insurance program for low-income people, in a lawsuit unsealed on Monday.
Properly done tests frequently showed that the drug failed to dissolve as it was supposed to, a sign that it would not be released in the body as expected, the lawsuit said.
The lawsuit also alleged that Pfizer, despite knowing of the quality-control issues, persuaded Texas’ Medicaid program to add Quillivant to its list of preferred drugs.
Pfizer said in a statement that it had examined the allegations in the complaint on “multiple occasions” and “did not find any impact on the safety of the product.”
A spokesperson for Tris said in an email: “We categorically deny and intend to rigorously defend these allegations in the court of law.”
In its 2022 annual report, Pfizer said it had received a subpoena from federal prosecutors in the Manhattan-based Southern District of New York related to its relationship with Tris and the production of Quillivant in 2018, but had not heard anything further after responding.
The original article contains 390 words, the summary contains 196 words. Saved 50%. I’m a bot and I’m open source!
This is the best summary I could come up with:
Nov 20 (Reuters) - Texas Attorney General Ken Paxton accused Pfizer (PFE.N) and its supplier Tris Pharma of providing children’s ADHD medicine that it knew might be ineffective to the state’s Medicaid insurance program for low-income people, in a lawsuit unsealed on Monday.
Properly done tests frequently showed that the drug failed to dissolve as it was supposed to, a sign that it would not be released in the body as expected, the lawsuit said.
The lawsuit also alleged that Pfizer, despite knowing of the quality-control issues, persuaded Texas’ Medicaid program to add Quillivant to its list of preferred drugs.
Pfizer said in a statement that it had examined the allegations in the complaint on “multiple occasions” and “did not find any impact on the safety of the product.”
A spokesperson for Tris said in an email: “We categorically deny and intend to rigorously defend these allegations in the court of law.”
In its 2022 annual report, Pfizer said it had received a subpoena from federal prosecutors in the Manhattan-based Southern District of New York related to its relationship with Tris and the production of Quillivant in 2018, but had not heard anything further after responding.
The original article contains 390 words, the summary contains 196 words. Saved 50%. I’m a bot and I’m open source!